All Type of News
KFDA okays bioequivalence testing of Ultracet generic
The Korea Food and Drug Administration said on September 8 it approved the bioequivalence test of Pacifc Pharm’s Expain, a generic version of the painkiller Ultracet.
Ultracet combines acetaminophen, the main ingre...
Government to scrap 1,104 medicines containing asbestos
The government said it has ordered drug makers to scrap 1,104 medicines confirmed to have used talc contaminated with asbestos within this month, according to the Korea Food and Drug Administration.
The drug agency...
Samyang Genex to gear up for supply of docetaxel to generic drugmakers
Samyang Geex has unveiled its plan to manufacture the first industrial-scale current good manufacturing practice (cGMP) batch of its key intermediate for docetaxel, the active pharmaceutical ingredient (API) of Sanofi...
Swine flu boosts sales of hand sensitizers
Influenza A fears are becoming an increasing boon for companies making hand sensitizers - so much so that they're having trouble keeping up with demand. Using a liquid or gel hand sensitizer is common and an everyday ...
Government to overhaul drug pricing system
The health ministry pledged to stamp out unethical practices in the pharmaceutical industry at a health care forum held in National Assembly on September 7, hinting that the current drug pricing system should be ameli...
Pharmaceutical firms developing lipid-lowering medicines
Korean pharmaceutical firms are preparing to challenge AstraZeneca’s grip on the lipid-lowering medicine market with generics of rosuvastatin, according to the Korea Food and Drug Administration.
According to the ...
Tamiflu shortfall for children predicted
A lawmaker points out that the storage of antiviral drugs to fight the virus after infection isn't enough for children under 14 years of age.
“Korea has stockpiles of Tamiflu for 125,400 children,” Rep. Kwak Jung-s...
Boryung to bid for flu vaccine program
Korea's Boryung Pharmaceutical Co. says it will bid to supply flu vaccines to the Korean goverment as it looks to inoculate millions in Korea
“Time is pressing because we will be able to provide vaccines by Novembe...
Otsuka Pharmaceutical to invest 100 billion won in Korea
Otsuka Pharmaceutical Co., one of Japan's leading drug companies, will invest around 100 billion won in Korea on research and development activities over the next five years.
The company president Iwamoto and Korea...
Government urged to adopt new drug pricing system
Byun Jae-hwan, a research fellow of the Health and Welfare Assembly said that the government should implement controversial drug pricing and reimbursement policies as early as possible despite opposition from pharmace...
